ATE285772T1 - Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten - Google Patents

Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten

Info

Publication number
ATE285772T1
ATE285772T1 AT99910150T AT99910150T ATE285772T1 AT E285772 T1 ATE285772 T1 AT E285772T1 AT 99910150 T AT99910150 T AT 99910150T AT 99910150 T AT99910150 T AT 99910150T AT E285772 T1 ATE285772 T1 AT E285772T1
Authority
AT
Austria
Prior art keywords
dione
indole
oxime derivatives
ampa antagonists
ampa
Prior art date
Application number
AT99910150T
Other languages
English (en)
Inventor
Frank Waetjen
Joergen Drejer
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of ATE285772T1 publication Critical patent/ATE285772T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99910150T 1998-03-31 1999-03-30 Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten ATE285772T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK45298 1998-03-31
DK46298 1998-04-01
PCT/DK1999/000194 WO1999049864A1 (en) 1998-03-31 1999-03-30 Indole-2,3-dione-3-oxime derivatives for therapeutic use

Publications (1)

Publication Number Publication Date
ATE285772T1 true ATE285772T1 (de) 2005-01-15

Family

ID=26064032

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99910150T ATE285772T1 (de) 1998-03-31 1999-03-30 Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten

Country Status (10)

Country Link
US (1) US6239128B1 (de)
EP (1) EP1066037B1 (de)
JP (1) JP2002509885A (de)
AT (1) ATE285772T1 (de)
AU (1) AU751414B2 (de)
BG (1) BG104801A (de)
CA (1) CA2326576A1 (de)
DE (1) DE69922936T2 (de)
NZ (1) NZ507259A (de)
WO (1) WO1999049864A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2369746A1 (en) * 1999-05-19 2000-11-30 Neurosearch A/S Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
CA2394292A1 (en) * 2000-01-24 2001-08-02 Neurosearch A/S Isatine derivatives with neurotrophic activity
ES2250667T3 (es) 2001-07-13 2006-04-16 PHARMACIA & UPJOHN COMPANY LLC Hexahidroazepino(4,5-g)indoles e indolinas como ligandos del receptor 5-ht.
MXPA05002056A (es) * 2002-08-22 2005-06-08 Neurosearch As Metodo para la preparacion de enantiomeros de derivados de indol-2,3-diona-3-oxima.
AU2006317545B2 (en) * 2005-11-23 2012-04-12 Aros Pharma Aps Compositions and methods for modulating gated ion channels
CA2652307A1 (en) * 2006-04-10 2007-10-18 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20080021034A1 (en) * 2006-04-10 2008-01-24 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20100041691A1 (en) * 2006-09-12 2010-02-18 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
CN102653538A (zh) * 2011-03-04 2012-09-05 爱斯医药科技(南京)有限公司 Spd-502的制备方法
CN104725372B (zh) * 2015-01-28 2017-02-22 天津科技大学 四环吲哚生物碱衍生物及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026747A1 (en) * 1993-05-13 1994-11-24 Neurosearch A/S Ampa antagonists and a method of treatment therewith
GB9418357D0 (en) * 1994-09-12 1994-11-02 Chiroscience Ltd Amidation process
EE03355B1 (et) * 1994-09-14 2001-02-15 Neurosearch A/S Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamine ja kasutamine
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму

Also Published As

Publication number Publication date
CA2326576A1 (en) 1999-10-07
AU2921999A (en) 1999-10-18
US6239128B1 (en) 2001-05-29
DE69922936D1 (de) 2005-02-03
DE69922936T2 (de) 2005-12-08
BG104801A (en) 2001-04-30
NZ507259A (en) 2003-07-25
EP1066037A1 (de) 2001-01-10
JP2002509885A (ja) 2002-04-02
EP1066037B1 (de) 2004-12-29
AU751414B2 (en) 2002-08-15
WO1999049864A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
CY1106165T1 (el) Παραγωγα ινδολινονης για την τροποποιηση της c-kit πρωτεϊνικης τυροσινικης κινασης
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
ID26984A (id) Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
PT1187918E (pt) Antagonistas de tek
BR9509994A (pt) Derivados heterocíclicos aromáticos como inibidores de enzimas
EA200100058A1 (ru) 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов
DE60037578D1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
EA200001176A1 (ru) Гетероциклические ингибиторы p38
EA199900559A1 (ru) Замещенные, азотсодержащие гетероциклы в качестве ингибиторов протеинкиназы p38
EA200501253A1 (ru) Производные пиразоло[1,5-a][1,3,5]триазина в качестве лигандов каннабиноидных рецепторов
DE60234269D1 (de) Substituierte aryl 1,4-pyrazin derivate
ES2137320T3 (es) Derivados de decahidro-isoquinoleina.
WO2003020698A3 (en) Protein tyrosine kinase inhibitors
IS5543A (is) Nýr G próteintengdur viðtaki
ES2078257T3 (es) Antagonistas de aminoacidos excitantes.
DE69922936D1 (de) Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
TR199800956T1 (xx) Yeni �ndol-2, 3-diyon-3- oksim t�revleri.
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
ATE203519T1 (de) Chinolinderivate als antimalariamittel
DE60025639D1 (de) Substituierte diazepan
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
TR199902315T2 (xx) Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�.
TR199901380A2 (xx) Di-ya da triazo-spiro$4,5] dekan t�revleri
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1066037

Country of ref document: EP

REN Ceased due to non-payment of the annual fee